
Professor Annelies Zinkernagel, Prof Dr. Dr. med., MSc
Invasive Group A Streptococcal infections - why are they more frequent?
Biography
Education 2005-2009 Doctor of Philosophy (PhD), Graduate School of Biomedical Sciences, Burnham Institute for Medical Research, La Jolla, California, USA. PhD Supervisor: Victor Nizet 2005 Board certificate in Infectious Diseases (FMH), Switzerland 2002 Board certificate in Internal medicine (FMH), Switzerland 1991-1997 Medical School, Universities of Lausanne and Zurich, Switzerland
Employment history including current positions Since 8/2020 Director Department of Infectious Diseases and Hospital Epidemiology, USZ Since 9/2019 Professor and Chair Infectious Diseases and Hospital Epidemiology, UZH 8/2015- 8/19 Assistant Professor for experimental infectious diseases, UZH Since 2010 Research Group Leader experimental infectious diseases, USZ 2009-2013 Attending (Oberärztin), University Hospital Zurich, Switzerland 2002-2005 Attending (OA i.V.), University Hospital Zurich, Switzerland
Approved research projects (selected) 2022-2024 Clinical research priority program UZH: BacVivo – Precision medicine for bacterial infections (PI, Co-PI B. Hasse), CHF 1.5 Mio 2021-2025 Swiss National Science Foundation (SNF): Tackling difficult-to-treat Staphylococcus aureus infections (PI), CHF 959’087 2020 -2024 National Centres of Competence in Research (NCCR): AntiResist, PI: Ch. Dehio, 51NF40_180541 (CHF 17 Mio). Role: project leader 2020 – 2021 Uniscientia Stiftung (PI), CHF 250’000 2019 - 2021 Clinical research priority program UZH: BacVivo – Precision medicine for bacterial infections (PI, Co-PI B. Hasse), CHF 1.5 Mio 2019-2021 SNF Biolink: Infect.Diseases Biobank Zurich (main applicant), 758'306 CHF 2018 Personalized Swiss Sepsis Study (PSSS): Detection and modelling of sepsis using machine learning to analyse continuous ICU monitoring, laboratory, microbiology, and -omics data for personalized sepsis management (Co-applicant), 2’400’000 CHF
Board memberships 2014 to date Member of the Executive Committee of European Society of Clinical Microbiology and Infectious Diseases (ESCMID). President since 4/2022 2014-2023 Member of the Eidgenössische Kommission für Impffragen (EKIF) Member of the program committee of the Annual Infectious Diseases Symposium Swiss Academic Foundation for Education in Infectious Diseases (SAFE-ID) Editorial boards: 2012-2015 Journal Frontiers in Infectious Diseases, associate editor 2011 Journal of Molecular Medicine (J Mol Med), member of the editorial board Regular or sporadic reviewing: J Mol Med, Science Translational, Science, Science Reports, Swiss Medical Weekly, Toxins, Clinical Microbiology Infection, Frontiers, Infection, Infection and Immunity, International Journal of Infectious Diseases Reviewing for funding agencies: Swiss National Science Foundation (SNF - Switzerland); Deutsche Forschungsgemeinschaft (DFG - Germany); Agence Nationale de la Recherche (ANR - France)
Active memberships in scientific societies, fellowships in renowned academies European Society of Clinical Microbiology and Infectious Diseases (ESCMID), American Society of Microbiology (ASM), Swiss Society for Microbiology, Swiss Society of Internal Medicine, Swiss Society for Infectious Diseases, Swiss Medical Association (FMH)